MARCELLO, ELENA
MARCELLO, ELENA
Dipartimento di Scienze Farmacologiche e Biomolecolari Rodolfo Paoletti
Cyclase-associated protein 2 gene delivery: A potential multi-target approach for preventing synaptic failure in Alzheimer’s disease
2026 R. Stringhi, S. Pelucchi, L. D'Andrea, F. La Greca, E. Zianni, L. Targa, C. Mosconi, L. Vandermeulen, M. Ascagni, M.C. Speciani, F. Gardoni, D. Scheggia, V. Edefonti, M. Di Luca, E. Marcello
Nonlinear mixed-effects models to analyze actin dynamics in dendritic spines
2025 G. Di Credico, S. Pelucchi, F. Pauli, R. Stringhi, E. Marcello, V. Edefonti
Cerebrospinal fluid cyclase-associated protein 2 is increased in Alzheimer's disease and correlates with tau pathology
2025 A. Padovani, A. Pilotto, S. Pelucchi, L. D'Andrea, R. Stringhi, F. Gorla, B. Aksan, S. Caratozzolo, A. Benussi, A. Galli, C. Tirloni, D. Mauceri, A. Canale, S. Archetti, B. Borroni, M. Di Luca, E. Marcello
Loss of PLA2G4E compromises synaptic structure and cognitive outcomes in mice
2025 S. Badesso, M. Perez-Gonzalez, S. Exposito, M. Espelosin, C. Cambria, L. D'Andrea, G. Imperato, P. Moeini, A. Vales, G. Gonzalez-Aseguinolaza, N. Mitro, F. Antonucci, E.D. Martín, E. Marcello, M. Cuadrado-Tejedor, A. Garcia-Osta
Neuronal PCSK9 regulates cognitive performances via the modulation of ApoER2 synaptic localization
2025 S. Pelucchi, L.D. Dalt, G.D. Cesare, R. Stringhi, L. D'Andrea, F.L. Greca, C. Cambria, L. Vandermeulen, E. Zianni, S. Musardo, S. Roda, F. Bonacina, S. Nasini, M.G. Lupo, N. Ferri, S. Comai, F. Gardoni, F. Antonucci, D. Scheggia, M.D. Luca, G.D. Norata, E. Marcello
Behavioral inflexibility through overtraining is mediated by reduced mGluR1/5 signaling capacity in the dorsolateral striatum
2025 V. Paget-Blanc, A. Cavaccini, A. Longaretti, L. Nava, M. Trusel, A. Rocchi, M. Pennuto, E. Marcello, F. Gardoni, B. Greco, R. Tonini
Arg209Lys and Gln508His missense variants in Rabphilin 3A cause pre- and post-synaptic dysfunctions at excitatory glutamatergic synapses
2025 M. Barzasi, A. Spinola, A. Costa, L. Pavinato, A. Brusco, E. Marcello, M. Diluca, F. Gardoni
Effects of the VIVIFRAIL Exercise Protocol on Circulatory and Intracellular Peripheral Mediators Bridging Mitochondrial Dynamics and Inflammation in Robust and Frail Older People
2025 F. Limanaqi, E. Ferri, P. Ogno, F.R. Guerini, G.A. Mihali, T. Lucchi, M. Clerici, C. Fenoglio, L. D'Andrea, E. Marcello, M. Biasin, B. Arosio
ADAM10 isoforms: Optimizing usage of antibodies based on protein regulation, structural features, biological activity and clinical relevance to Alzheimer's disease
2024 S. Dorta, V. Alexandre-Silva, C.P. Popolin, D.B. de Sousa, M.M. Grigoli, L.N.D.C. Pelegrini, P.R. Manzine, A. Camins, E. Marcello, K. Endres, M.R. Cominetti
Glucose-derived glutamate drives neuronal terminal differentiation in vitro
2024 L. D'Andrea, M. Audano, S. Pedretti, S. Pelucchi, R. Stringhi, G. Imperato, G. De Cesare, C. Cambria, M.H. Laporte, N. Zamboni, F. Antonucci, M. Di Luca, N. Mitro, E. Marcello
New Views of the DNA Repair Protein Ataxia–Telangiectasia Mutated in Central Neurons: Contribution in Synaptic Dysfunctions of Neurodevelopmental and Neurodegenerative Diseases
2023 S. Briguglio, C. Cambria, E. Albizzati, E. Marcello, G. Provenzano, A. Frasca, F. Antonucci
Beyond the unfolded protein response: Disclosing the role of XBP1s in Alzheimer’s disease
2023 E. Marcello
An association study of cyclase-associated protein 2 and frailty
2023 S. Pelucchi, C. Macchi, L. D'Andrea, P.D. Rossi, M.C. Speciani, R. Stringhi, M. Ruscica, B. Arosio, M. Di Luca, M. Cesari, V. Edefonti, E. Marcello
Novel therapeutic approaches to target neurodegeneration
2023 A.G. de la Fuente, S.C. Pelucchi, J. Mertens, M.M.G. Diluca, D. Mauceri, E. Marcello
Rabphilin-3A as a novel target to reverse α-synuclein-induced synaptic loss in Parkinson's disease
2022 E. Ferrari, D. Scheggia, E. Zianni, M. Italia, M. Brumana, L. Palazzolo, C. Parravicini, A. Pilotto, A. Padovani, E. Marcello, I. Eberini, P. Calabresi, M. Diluca, F. Gardoni
The epilepsy-associated protein PCDH19 undergoes NMDA receptor-dependent proteolytic cleavage and regulates the expression of immediate-early genes
2022 L. Gerosa, S. Mazzoleni, F. Rusconi, A. Longaretti, E. Lewerissa, S. Pelucchi, L. Murru, S.G. Giannelli, V. Broccoli, E. Marcello, N.N. Kasri, E. Battaglioli, M. Passafaro, S. Bassani
Synaptic dysfunction in early phases of Alzheimer's Disease
2022 S. Pelucchi, F. Gardoni, M. Di Luca, E. Marcello
The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer's disease
2022 S. Musardo, S. Therin, S. Pelucchi, L. D'Andrea, R. Stringhi, A. Ribeiro, A. Manca, C. Balducci, J. Pagano, C. Sala, C. Verpelli, V. Grieco, V. Edefonti, G. Forloni, F. Gardoni, G. Meli, D. Di Marino, M. Di Luca, E. Marcello
Disease association of cyclase-associated protein (CAP): Lessons from gene-targeted mice and human genetic studies
2022 M.B. Rust, E. Marcello
Analysis of mRNA and Protein Levels of CAP2, DLG1 and ADAM10 Genes in Post‐Mortem Brain of Schizophrenia, Parkinson’s and Alzheimer’s Disease Patients
2022 A.D. Maio, A. De Rosa, S. Pelucchi, M. Garofalo, B. Marciano, T. Nuzzo, F. Gardoni, A.M. Isidori, M. Di Luca, F. Errico, A. De Bartolomeis, E. Marcello, A. Usiello